Literature DB >> 28644701

Comparison between Briganti, Partin and MSKCC tools in predicting positive lymph nodes in prostate cancer: a systematic review and meta-analysis.

Sebastiano Cimino1, Giulio Reale1, Tommaso Castelli1, Vincenzo Favilla1, Raimondo Giardina1, Giorgio Ivan Russo1, Salvatore Privitera1, Giuseppe Morgia1.   

Abstract

OBJECTIVE: The aim of this study was to analyze the discriminative capabilities of Briganti, Partin and Memorial Sloan Kettering Cancer Center (MSKCC) nomograms in predicting lymph-node invasion (LNI) and to perform a meta-analysis to yield pooled area under the receiver operating characteristics curves (AUCs) for model comparison.
MATERIALS AND METHODS: An electronic search of the MEDLINE and Embase databases up to October 2016 was undertaken. The AUC value, total number of patients and rate of LNI were extracted from the included references. After excluding redundant literature, 19 studies were identified including 86,338 patients. The Briganti, Partin and MSKCC nomograms were validated in 6629, 69,681 and 10,028 patients, respectively.
RESULTS: The pooled AUCs for Briganti, Partin, and MSKCC nomograms were 0.793, 0.778 and 0.780, respectively. The Mantel-Haenszel-derived comparison of AUC values revealed no statistical differences of predictive capabilities for Briganti vs Partin (p = 0.23), Briganti vs MSKCC (p = 0.83) and Partin vs MSKCC (p = 0.26). The accuracy of Briganti, Partin and MSKCC models is statistically similar in predicting the presence of LNI. International guidelines could consider these findings by reporting similarities in the accuracy of these models.
CONCLUSIONS: The accuracy of Briganti, Partin and MSKCC was similar in predicting the presence of LNI. Based on these results, patients and clinicians may use any of these nomograms without significant advantages.

Entities:  

Keywords:  Lymph node; lymph-node dissection; meta-analysis; nomogram; prostate cancer

Mesh:

Year:  2017        PMID: 28644701     DOI: 10.1080/21681805.2017.1332680

Source DB:  PubMed          Journal:  Scand J Urol        ISSN: 2168-1805            Impact factor:   1.612


  10 in total

1.  Development of a novel nomogram to identify the candidate to extended pelvic lymph node dissection in patients who underwent mpMRI and target biopsy only.

Authors:  Cristian Fiori; Enrico Checcucci; Ilaria Stura; Daniele Amparore; Sabrina De Cillis; Alberto Piana; Stefano Granato; Gabriele Volpi; Michele Sica; Federico Piramide; Paolo Verri; Matteo Manfredi; Stefano De Luca; Riccardo Autorino; Giuseppe Migliaretti; Francesco Porpiglia
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-06-24       Impact factor: 5.554

2.  Development and Validation of Models to Predict Pathological Outcomes of Radical Prostatectomy in Regional and National Cohorts.

Authors:  Erkin Ötleş; Brian T Denton; Bo Qu; Adharsh Murali; Selin Merdan; Gregory B Auffenberg; Spencer C Hiller; Brian R Lane; Arvin K George; Karandeep Singh
Journal:  J Urol       Date:  2021-09-23       Impact factor: 7.450

3.  Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging.

Authors:  Dennie Meijer; Pim J van Leeuwen; Maarten L Donswijk; Thierry N Boellaard; Ivo G Schoots; Henk G van der Poel; Harry N Hendrikse; Daniela E Oprea-Lager; André N Vis
Journal:  BJU Int       Date:  2021-06-16       Impact factor: 5.969

Review 4.  A narrative review of pelvic lymph node dissection in prostate cancer.

Authors:  Douglas C Cheung; Neil Fleshner; Shomik Sengupta; Dixon Woon
Journal:  Transl Androl Urol       Date:  2020-12

5.  Artificial Intelligence Combined With Big Data to Predict Lymph Node Involvement in Prostate Cancer: A Population-Based Study.

Authors:  Liwei Wei; Yongdi Huang; Zheng Chen; Hongyu Lei; Xiaoping Qin; Lihong Cui; Yumin Zhuo
Journal:  Front Oncol       Date:  2021-10-14       Impact factor: 6.244

Review 6.  THE ROLE OF LYMPHADENECTOMY IN PROSTATE CANCER PATIENTS.

Authors:  Dean Markić; Romano Oguić; Kristian Krpina; Ivan Vukelić; Gordana Đorđević; Iva Žuža; Josip Španjol
Journal:  Acta Clin Croat       Date:  2019-11       Impact factor: 0.780

Review 7.  Utility of Lymphadenectomy in Prostate Cancer: Where Do We Stand?

Authors:  Bartosz Małkiewicz; Paweł Kiełb; Jakub Karwacki; Róża Czerwińska; Paulina Długosz; Artur Lemiński; Łukasz Nowak; Wojciech Krajewski; Tomasz Szydełko
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.241

8.  Robotic perineal radical prostatectomy and robotic pelvic lymph node dissection via a perineal approach: The Tugcu Bakirkoy Technique.

Authors:  Volkan Tuğcu; Oktay Akça; Abdulmuttalip Şimşek; İsmail Yiğitbaşı; Mustafa Gürkan Yenice; Selçuk Şahin; Ali İhsan Taşcı
Journal:  Turk J Urol       Date:  2018-03-01

9.  Expanding the Utilization of Rectal Spacer Hydrogel for Larger Prostate Glands (>80 cc): Feasibility and Dosimetric Outcomes.

Authors:  Marcio Fagundes; Maria Amelia Rodrigues; Steve Olszewski; Fazal Khan; Craig McKenzie; Alonso Gutierrez; Michael Chuong; Minesh Mehta
Journal:  Adv Radiat Oncol       Date:  2021-01-16

10.  External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer.

Authors:  Daimantas Milonas; Zilvinas Venclovas; Tim Muilwijk; Mindaugas Jievaltas; Steven Joniau
Journal:  Cent European J Urol       Date:  2020-03-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.